Public Service Company of Oklahoma (PSO) customers who experienced weather-related outages during the July 5th storm should ...

A single tick bite can change what you eat for the rest of your life. Oklahoma is taking a new step to better understand the ...

A research team has developed an optimized energy management strategy for a hybrid residential microgrid that combines solar ...

Takeda (TAK) says its tyrosine kinase inhibitor, zasocitinib, significantly outperformed deucravacitinib, a rival therapy marketed by Bristol-Myers (BMY) as Sotyktu, in a late-stage trial for patients ...